» Articles » PMID: 11979335

Calibration and Random Variation of the Serum Creatinine Assay As Critical Elements of Using Equations to Estimate Glomerular Filtration Rate

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 2002 Apr 30
PMID 11979335
Citations 218
Authors
Affiliations
Soon will be listed here.
Abstract

Equations using serum creatinine level, age, sex, and other patient characteristics often are used to estimate glomerular filtration rate (GFR) in both clinical practice and research studies. However, the critical dependence of these equations on serum creatinine assay calibration often is overlooked, and the reproducibility of estimated GFR is rarely discussed. We address these issues in frozen samples from 212 Modification of Diet in Renal Disease (MDRD) study participants and 342 Third National Health and Nutrition Examination Survey (NHANES III) participants assayed for serum creatinine level a second time during November 2000. Variation in serum creatinine level was assessed in 1,919 NHANES III participants who had serum creatinine measured on two visits a median of 17 days apart. Linear regression was used to compare estimates. Calibration of serum creatinine varied substantially across laboratories and time. Data indicate that serum creatinine assays on the same samples were 0.23 mg/dL higher in the NHANES III than MDRD study. Data from the College of American Pathologists suggest that a difference of this magnitude across laboratories is not unusual. Conversely, serum creatinine assays an average of 2 weeks apart have better precision (SD of percentage of difference in estimated GFR, 15%; 90% of estimates within 21%). Errors in calibration make little difference in estimating severely decreased GFR (<30 mL/min/1.73 m2), but result in progressively larger differences at higher GFRs. Both clinical and research use of serum creatinine or equations to estimate GFR require knowledge of the calibration of the serum creatinine assay.

Citing Articles

Kidney function estimation equations: a narrative review.

Khader N, Kamath V, Kamath S, Rao I, Prabhu A Ir J Med Sci. 2025; .

PMID: 39873963 DOI: 10.1007/s11845-025-03874-y.


Impairment of Cardiovascular Functional Capacity in Mild-to-Moderate Kidney Dysfunction.

Lim K, Nayor M, Arroyo E, Burney H, Li X, Li Y Clin J Am Soc Nephrol. 2024; 19(12):1547-1561.

PMID: 39401313 PMC: 11637711. DOI: 10.2215/CJN.0000000000000548.


The influence of calibration on bias in quality control and patient results for TSH on Vitros XT 7600 analyzer.

Boreyko J, Ivica J Biochem Med (Zagreb). 2024; 34(3):030703.

PMID: 39171090 PMC: 11334199. DOI: 10.11613/BM.2024.030703.


Chronic kidney disease and cognitive performance: NHANES 2011-2014.

Li T, Hu Z, Qiao L, Wu Y, Ye T BMC Geriatr. 2024; 24(1):351.

PMID: 38637739 PMC: 11027402. DOI: 10.1186/s12877-024-04917-2.


Effectiveness  of a Disease Management Program (DMP) in controlling the progression of Chronic Kidney Disease among hypertensives and diabetics.

Sequira L, Prabhu A R, Mayya S, Nagaraju S, Nayak B F1000Res. 2024; 11:1111.

PMID: 38576797 PMC: 10993008. DOI: 10.12688/f1000research.123787.3.